Starting Dose for Lantus (Insulin Glargine)
The recommended starting dose for Lantus (insulin glargine) is 10 units per day or 0.1-0.2 units/kg of body weight for insulin-naive patients. 1
Initial Dosing Guidelines
For patients with type 1 diabetes:
- Starting dose typically ranges from 0.4 to 1.0 units/kg/day of total insulin 2
- The American Diabetes Association/JDRF Type 1 Diabetes Sourcebook recommends 0.5 units/kg/day as a typical starting dose for metabolically stable patients 2
- Higher doses may be required during puberty or immediately following ketoacidosis 2
For patients with type 2 diabetes:
Dose Titration
- Adjust dose by 2 units once or twice weekly until fasting glucose target is reached 1
- Decrease dose by 2 units if fasting glucose falls below target or if hypoglycemic episodes occur 1
- Target fasting blood glucose should be ≤110 mg/dL for optimal HbA1c control 3
Special Considerations
Timing of administration: Lantus can be administered at bedtime, before breakfast, or before dinner with similar glycemic control outcomes 4
- Morning administration may result in fewer nocturnal hypoglycemic events compared to bedtime dosing (59.5% vs 77.5%) 4
For patients requiring high insulin doses (obese, insulin-resistant):
For patients with specific conditions:
Common Pitfalls to Avoid
- Inadequate dose titration: Timely dose adjustment is critical for achieving glycemic targets 1
- Overbasalization: Be cautious if basal dose exceeds 0.5 units/kg with inadequate glucose control 1
- Mixing with other insulins: Lantus should not be mixed with other insulin formulations due to its low pH 1
- Ignoring postprandial hyperglycemia: Lantus does not address post-meal glucose surges; additional prandial insulin may be needed 5
Practical Formula for Dose Calculation
A simplified formula for calculating the optimal Lantus dose at 24 weeks 6:
- Optimal daily dose = Starting dose (0.15 × weight in kg) + Incremental dose (baseline HbA1c - target HbA1c + 2)
This formula provides a practical approach to dose optimization but should be adjusted based on individual patient factors and response to therapy.